New trends for the medical treatment of endometriosis

Bibliography

• Giudice LC. Clinical practice. Endometriosis. N Engl J Med 2010;362(25):2389-98
   PubMed Web of Science ®Google Scholar
• Bulun SE. Endometriosis. N Engl J Med 2009;360(3):268-79
   PubMed Web of Science ®Google Scholar
• Fauconnier A, Chapron C. Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications. Hum Reprod Update 2005;11:595-606
   PubMed Web of Science ®Google Scholar
• Milingos S, Protopapas A, Drakakis P, Laparoscopic management of patients with endometriosis and chronic pelvic pain. Ann NY Acad Sci 2003;997:269-73
   PubMed Web of Science ®Google Scholar
• Kennedy S, Bergqvist A, Chapron C, ESHRE guideline for the diagnosis and treatment of endometriosis. ESHRE Special Interest Group for Endometriosis and Endometrium Guideline Development Group. Hum Reprod 2005;20(10):2698-704
   PubMed Web of Science ®Google Scholar
• Berkley KJ, Rapkin AJ, Papka RE. The pains of endometriosis. Science 2005;308:1587-9; Endocrinology. 6th edition. Elsevier, New York; 2010. p. 2356-70
   PubMed Web of Science ®Google Scholar
• Tokushige N, Markham R, Russell P, Fraser IS. Nerve fibres in peritoneal endometriosis. Hum Reprod 2006;21:3001-7
   PubMed Web of Science ®Google Scholar
• Giudice LC, Kao LC. Endometriosis. Lancet 2004;364(9447):1789-99
   PubMed Web of Science ®Google Scholar
• Beretta P, Franchi M, Ghezzi F, Randomized clinical trial of two laparoscopic treatments of endometriomas: cystectomy versus drainage and coagulation. Fertil Steril 1998;70:1176-80
   PubMed Web of Science ®Google Scholar
• Chapron C, Vercellini P, Barakat H, Management of ovarian endometriomas. Hum Reprod Update 2002;8:6-7
   Google Scholar
• Vercellini P, Chapron C, De Giorgi O, Coagulation or excision of ovarian endometriomas? Am J Obstet Gynecol 2003;188:606-10
   PubMed Web of Science ®Google Scholar
• Dousset B, Leconte M, Borghese B, Complete surgery for low rectal endometriosis: long-term results of a 100-case prospective study. Ann Surg 2010;251(5):887-95
   PubMed Web of Science ®Google Scholar
• Moore J, Kennedy SH, Prentice A. Modern combined oral contraceptives for pain associated with endometriosis (Cochrane Review). In: The Cochrane Library. Issue 3. John Wiley & Sons Ltd; Chichester, UK: 2004
   Google Scholar
• Prentice A, Deary AJ, Goldbeck WS, Farquhar C. Smith SK Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. In: The Cochrane Library. Issue 3. John Wiley & Sons Ltd; Chichester, UK: 2004
   Google Scholar
• Selak V, Farquhar C, Prentice A, Singla A. Danazol for pelvic pain associated with endometriosis (Cochrane Review). In: The Cochrane Library. Issue 3. John Wiley & Sons Ltd; Chichester, UK: 2004
   Google Scholar
• Bahamondes L, Petta CA, Fernandes A, Monteiro I. Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea. Contraception 2007;75(6 Suppl):S134-9
   PubMed Web of Science ®Google Scholar
• Kauppila A, Ronnberg L. Naproxen sodium in dysmenorrhea secondary to endometriosis. Obstet Gynecol 1985;65:379-83
   PubMed Web of Science ®Google Scholar
• Kauppila A, Puolakka J, Ylikorkala O. Prostaglandin biosynthesis inhibitors and endometriosis. Prostaglandins 1979;18:655-61
   PubMedGoogle Scholar
• Huirne JA, Lambalk CB. Gonadotropin-releasing-hormone-receptor antagonists. Lancet 2001;358(9295):1793-803
   PubMed Web of Science ®Google Scholar
• Struthers RS, Nicholls AJ, Grundy J, Suppression of gonadotropins and estradiol in premenopausal women by oral administration of the nonpeptide gonadotropin-releasing hormone antagonist elagolix. J Clin Endocrinol Metab 2009;94(2):545-51
   PubMed Web of Science ®Google Scholar
• Carr B, Chwalisz K, Jimenez R, Elagolix, a novel oral GnRH antagonist, maintained reduction of endometriosis-associated pelvic pain during 24 weeks of treatments. Abstract Book. 11th World Congress on Endometriosis; 2011. p. 176-7
   Google Scholar
• Al Kadri H, Hassan S, Al-Fozan HM, Hajeer A. Hormone therapy for endometriosis and surgical menopause. Cochrane Database Syst Rev 2009(1):CD005997
   Google Scholar
• Meresman GF, Bilotas M, Abello V, Effects of aromatase inhibitors on proliferation and apoptosis in eutopic endometrial cell cultures from patients with endometriosis. Fertil Steril 2005;84:459-63
   PubMed Web of Science ®Google Scholar
• Noble LS, Simpson ER, Johns A, Bulun SE. Aromatase expression in endometriosis. J Clin Endocrinol Metab 1996;81:174-9
   PubMed Web of Science ®Google Scholar
• Kitawaki J, Noguchi T, Amatsu T, Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biol Reprod 1997;57:514-19
   PubMed Web of Science ®Google Scholar
• Kitawaki J, Kusuki I, Koshiba H, Detection of aromatase cytochrome P-450 in endometrial biopsy specimens as a diagnostic test for endometriosis. Fertil Steril 1999;72:1100-6
   PubMed Web of Science ®Google Scholar
• Wolfler MM, Nagele F, Kolbus A, A predictive model for endometriosis. Hum Reprod 2005;20:1702-8
   PubMed Web of Science ®Google Scholar
• Velasco I, Rueda J, Acien P. Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis. Mol Hum Reprod 2006;12:377-81
   PubMed Web of Science ®Google Scholar
• Hudelist G, Czerwenka K, Keckstein J, Expression of aromatase and estrogen sulfotransferase in eutopic and ectopic endometrium: evidence for unbalanced estradiol production in endometriosis. Reprod Sci 2007;14:798-805
   PubMed Web of Science ®Google Scholar
• Smuc T, Hevir N, Ribic-Pucelj M, Disturbed estrogen and progesterone action in ovarian endometriosis. Mol Cell Endocrinol 2009;301:59-64
   PubMed Web of Science ®Google Scholar
• Ferrero S, Gillott DJ, Venturini PL, Remorgida V. Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review. Reprod Biol Endocrinol 2011;9(1):89
   PubMedGoogle Scholar
• Ailawadi RK, Jobanputra S, Kataria M, Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. Fertil Steril 2004;81:290-6
   PubMed Web of Science ®Google Scholar
• Amsterdam LL, Gentry W, Jobanputra S, Anastrazole and oral contraceptives: a novel treatment for endometriosis. Fertil Steril 2005;84:300-4
   PubMed Web of Science ®Google Scholar
• Hefler LA, Grimm C, van Trotsenburg M, Nagele F. Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study. Fertil Steril 2005;84:1033-6
   PubMed Web of Science ®Google Scholar
• Remorgida V, Abbamonte LH, Ragni N, Letrozole and desogestrel-only contraceptive pill for the treatment of stage IV endometriosis. Aust NZ J Obstet Gynaecol 2007;47:222-5
   PubMed Web of Science ®Google Scholar
• Remorgida V, Abbamonte HL, Ragni N, Letrozole and norethisterone acetate in rectovaginal endometriosis. Fertil Steril 2007;88:724-6
   PubMed Web of Science ®Google Scholar
• Razzi S, Fava A, Sartini A, Treatment of severe recurrent endometriosis with an aromatase inhibitor in a young ovariectomised woman. BJOG 2004;111(2):182-4
   PubMed Web of Science ®Google Scholar
• Luisi S, Lazzeri L, Ciani V, Petraglia F. Endometriosis in Italy: from cost estimates to new medical treatment. Gynecol Endocrinol 2009;25(11):734-40
   PubMed Web of Science ®Google Scholar
• Ferrero S, Camerini G, Seracchioli R, Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis. Hum Reprod 2009;24:3033-41
   PubMed Web of Science ®Google Scholar
• Soysal S, Soysal ME, Ozer S, The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial. Hum Reprod 2004;19:160-7
   PubMed Web of Science ®Google Scholar
• Lossl K, Loft A, Freiesleben NLC, Combined down-regulation by aromatase inhibitor and GnRH-agonist in IVF patients with endometriosis – a pilot study. Eur J Obstet Gynecol Reprod Biol 2009;144:48-53
   PubMed Web of Science ®Google Scholar
• Vercellini P, Somigliana E, Vigano P, Endometriosis: current and future medical therapies. Best Pract Res Clin Obstet Gynaecol 2008;22(2):275-306
   PubMed Web of Science ®Google Scholar
• Stygar D, Muravitskaya N, Eriksson B, Effects of SERM (selective estrogen receptor modulator) treatment on growth and proliferation in the rat uterus. Reprod Biol Endocrinol 2003;1:40
   PubMedGoogle Scholar
• Kulak J Jr, Fischer C, Komm B, Taylor HS. Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model. Endocrinology 2011; Epub ahead of print
   PubMed Web of Science ®Google Scholar
• Saito T, Yaoshizawa M, Yamauchi Y, Effects of the novel orally active antiestrogen TZE-5323 on experimental endometriosis. Arzneimittelforschung Drug Res 2003;53:507-14
   Google Scholar
• Yao Z, Shen X, Capodanno I, Validation of rat endometriosis model by using raloxifene as a positive control for the evaluation of novel SERM compounds. J Invest Surg 2005;18:177-83
   PubMed Web of Science ®Google Scholar
• Yavuz E, Oktem M, Esinler I, Genistein causes regression of endometriotic implants in the rat model. Fertil Steril 2007;88(4 Suppl):1129-34
   PubMedGoogle Scholar
• Altintas D, Kokcu A, Kandemir B, Comparison of the effects of raloxifene and anastrozole on experimental endometriosis. Eur J Obstet Gynecol Reprod Biol 2010;150(1):84-7
   PubMed Web of Science ®Google Scholar
• Stratton P, Sinaii N, Segars J, Return of chronic pelvic pain from endometriosis after raloxifene treatment: a randomized controlled trial. Obstet Gynecol 2008;111(1):88-96
   PubMed Web of Science ®Google Scholar
• Anthony M, Williams JK, Dunn BK. What would be the properties of an ideal SERM? Ann NY Acad Sci 2001;949:261-78
   PubMed Web of Science ®Google Scholar
• Chabbert-Buffet N, Meduri G, Bouchard P, Spitz IM. Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications. Hum Reprod Update 2005;11(3):293-307
   PubMed Web of Science ®Google Scholar
• Spitz IM. Mifepristone: where do we come from and where are we going? Clinical development over a quarter of a century. Contraception 2010;82(5):442-52
   PubMed Web of Science ®Google Scholar
• Huang HY. Medical treatment of endometriosis. Chang Gung Med J 2008;31(5):431-40
   PubMedGoogle Scholar
• Chwalisz K, Garg R, Brenner RM, Selective progesterone receptor modulators (SPRMs): a novel therapeutic concept in endometriosis. Ann NY Acad Sci 2002;955:373-88
   PubMed Web of Science ®Google Scholar
• Wolf JP, Hsiu JG, Anderson TL, Non-competitive antiestrogenic effect of RU 486 in blocking the estrogen-stimulated luteinizing hormone surge and the proliferative action of estradiol on endometrium in castrate monkeys. Fertil Steril 1989;52:1055-60
   PubMed Web of Science ®Google Scholar
• Slayden OD, Zelinski-Wooten MB, Chwalisz K, Chronic treatment of cyclic rhesus monkeys with low doses of the antiprogestin ZK 137 316: morphometric assessment of the uterus and oviduct. Hum Reprod 1998;13:269-77
   PubMed Web of Science ®Google Scholar
• Hodgen GD, van Uem JFHM, Chilik CF, Non-competitive antioestrogenic activity of PAs in primate models. Hum Reprod 1994;9:77-82
   PubMed Web of Science ®Google Scholar
• Grow DR, Williams RF, Hsiu JG, Hodgen GD. Antiprogestin and/or gonadotropin-releasing hormone agonist for endometriosis treatment and bone maintenance: a 1-year primate study. J Clin Endocrinol Metab 1996;81:1933-9
   PubMed Web of Science ®Google Scholar
• Madauss KP, Grygielko ET, Deng SJ, A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulator. Mol Endocrinol 2007;21(5):1066-81
   PubMed Web of Science ®Google Scholar
• Chwalisz K, Perez MC, Demanno D, Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis. Endocr Rev 2005;26(3):423-38
   PubMed Web of Science ®Google Scholar
• Chwalisz K, Mattia-Goldberg K, Lee M, Treatment of endometriosis with the novel selective progesterone receptor modulator (SPRM) asoprisnil. Fertil Steril 2004;82:S83-4
   Web of Science ®Google Scholar
• Carli C, Metz CN, Al-Abed Y, Up-regulation of cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic cells by macrophage migration inhibitory factor: involvement of novel kinase signaling pathways. Endocrinology 2009;150(7):3128-37
   PubMed Web of Science ®Google Scholar
• Chishima F, Hayakawa S, Sugita K, Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients. Am J Reprod Immunol 2002;48(1):50-6
   PubMed Web of Science ®Google Scholar
• Cobellis L, Razzi S, De Simone S, The treatment with a COX-2 specific inhibitor is effective in the management of pain related to endometriosis. Eur J Obstet Gynecol Reprod Biol 2004;116(1):100-2
   PubMed Web of Science ®Google Scholar
• Ebert AD, Bartley J, David M. Aromatase inhibitors and cyclooxygenase-2 (COX-2) inhibitors in endometriosis: new questions–old answers? Eur J Obstet Gynecol Reprod Biol 2005;122(2):144-5
   PubMed Web of Science ®Google Scholar
• Machado DE, Berardo PT, Landgraf RG, A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis with an antiangiogenic effect in a rat model. Fertil Steril 2010;93(8):2674-9
   PubMed Web of Science ®Google Scholar
• Olivares C, Ricci A, Bilotas M, The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis. Fertil Steril 2011;96:428-33
   PubMed Web of Science ®Google Scholar
• Hull ML, Prentice A, Wang DY, Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis. Hum Reprod 2005;20(2):350-8
   PubMed Web of Science ®Google Scholar
• Novembri R, Luisi S, Carrarelli P, Omega 3 fatty acids counteract IL-8 and prostaglandinE2 secretion induced by TNF-alpha in cultured endometrial stromal cells. J Endometriosis 2011;3(1):34-9
   Google Scholar
• Critchley HOD, Osei J, Henderson TA, Hypoxia-inducible factor-1{alpha} expression in human endometrium and its regulation by prostaglandin E-Series Prostanoid Receptor2 (EP2). Endocrinology 2006;147:144-53
   Google Scholar
• Howard FM. Endometriosis and mechanisms of pelvic pain. J Minim Invasive Gynecol 2009;16:540-50
   PubMed Web of Science ®Google Scholar
• Chen DB, Yang ZM, Hilsenrath R, Stimulation of prostaglandin (PG) F2 alpha and PGE2 release by tumour necrosis factor-alpha and interleukin-1 alpha in cultured human luteal phase endometrial cells. Hum Reprod 1995;10:2773-80
   PubMed Web of Science ®Google Scholar
• Covens AL, Christopher P, Casper RF. The effect of dietary supplementation with fish oil fatty acids on surgically induced endometriosis in the rabbit. Fertil Steril 1988;49:698-703
   PubMed Web of Science ®Google Scholar
• Netsu S, Konno R, Odagiri K, Oral eicosapentaenoic acid supplementation as possible therapy for endometriosis. Fertil Steril 2008;90(4 Suppl):1496-502
   PubMedGoogle Scholar
• Chegini N, Tang XM, Dou Q. The expression, activity and regulation of granulocyte macrophage-colony stimulating factor in human endometrial epithelial and stromal cells. Mol Hum Reprod 1999;5:459-66
   PubMed Web of Science ®Google Scholar
• Nasu K, Fujisawa K, Arima K, Expression and regulation of growth-regulated oncogene alpha in human endometrial stromal cells. Mol Hum Reprod 2001;7:741-6
   PubMed Web of Science ®Google Scholar
• Boucher A, Kharfi A, Al-Akoum M, Cycle-dependent expression of interleukin-1 receptor type II in the human endometrium. Biol Reprod 2001;65:890-8
   PubMed Web of Science ®Google Scholar
• Rossi M, Sharkey AM, Vigano P, Identification of genes regulated by interleukin-1b in human endometrial stromal cells. Reproduction 2005;130:721-9
   PubMed Web of Science ®Google Scholar
• Harel Z, Biro FM, Kottenhahn RK, Rosenthal SL. Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in adolescents. Am J Obstet Gynecol 1996;174:1335-8
   PubMed Web of Science ®Google Scholar
• Gazvani MR, Smith L, Haggarty P, High omega-3:omega-6 fatty acid ratios in culture medium reduce endometrial-cell survival in combined endometrial gland and stromal cell cultures from women with and without endometriosis. Fertil Steril 2001;76(4):717-22
   PubMed Web of Science ®Google Scholar
• Lazzeri L, Luisi S, Sabbioni L, Omega-3 fatty acids in the treatment of endometriosis related pain. Abstract Book. 11th World Congress on Endometriosis; 2011. p. 181
   Google Scholar
• Franzoni F, Quinones-Galvan A, Regoli F, A comparative study of the in vitro antioxidant activity of statins. Int J Cardiol 2003;90:317-21
   PubMed Web of Science ®Google Scholar
• Foyouzi N, Berkkanoglu M, Arici A, Effects of oxidants and antioxidants on proliferation of endometrial stromal cells. Fertil Steril 2004;82(Suppl 3):1019-22
   PubMed Web of Science ®Google Scholar
• Piotrowski PC, Kwintkiewicz J, Rzepczynska IJ, Statins inhibit growth of human endometrial stromal cells independently of cholesterol availability. Biol Reprod 2006;75:107-11
   PubMed Web of Science ®Google Scholar
• Esfandiari N, Khazaei M, Ai J, Effect of a statin on an in vitro model of endometriosis. Fertil Steril 2007;87:257-62
   PubMed Web of Science ®Google Scholar
• Oktem M, Esinler I, Eroglu D, High-dose atorvastatin causes regression of endometriotic implants: a rat model. Hum Reprod 2007;22:1474-80
   PubMed Web of Science ®Google Scholar
• Bruner-Tran KL, Osteen KG, Duleba AJ. Simvastatin protects against the development of endometriosis in a nude mouse model. J Clin Endocrinol Metab 2009;94(7):2489-94
   PubMed Web of Science ®Google Scholar
• Wilson WR, Evans J, Bell PR, Thompson MM. HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2005;30:259-62
   PubMed Web of Science ®Google Scholar
• Furman C, Copin C, Kandoussi M, Rosuvastatin reduces MMP-7 secretion by human monocyte-derived macrophages: potential relevance to atherosclerotic plaque stability. Atherosclerosis 2004;174:93-8
   PubMed Web of Science ®Google Scholar
• Cho SJ, Kim JS, Kim JM, Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice. Int J Cancer 2008;123:951-7
   PubMed Web of Science ®Google Scholar
• Nap AW, Dunselman GA, de Goeij AF, Inhibiting MMP activity prevents the development of endometriosis in the chicken chorioallantoic membrane model. Hum Reprod 2004;19:2180-7
   PubMed Web of Science ®Google Scholar
• Sokalska A, Wong DH, Cress A, Simvastatin induces apoptosis and alters cytoskeleton in endometrial stromal cells. J Clin Endocrinol Metab 2010;95(7):3453-9
   PubMed Web of Science ®Google Scholar
• Wassmann S, Laufs U, Muller K, Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol 2002;22:300-5
   PubMed Web of Science ®Google Scholar
• Wieser F, Cohen M, Gaeddert A, Evolution of medical treatment for endometriosis: back to the roots? Hum Reprod Update 2007;13:487-99
   PubMed Web of Science ®Google Scholar
• Wieser F, Burks-Wicks C, Vigne J, Extracts from a traditional Chinese herbal remedy inhibit cell proliferation and induce apoptosis in human endometrial and endometriosis cells. In: Abstracts of the 61st Annual Meeting of the American Society for Reproductive Medicine, October 15–19, 2005, Montreal, Quebec, Canada. Fertil Steril 2005 84:S192; P113
   Google Scholar
• Lian F, Liu HP, Wang YX, Expressions of VEGF and Ki-67 in eutopic endometrium of patients with endometriosis and effect of Quyu Jiedu Recipe on VEGF expression. Chin J Integr Med 2007;13:109-14
   PubMed Web of Science ®Google Scholar
• Wieser F, Yu J, Park J, A botanical extract from channel flow inhibits cell proliferation, induces apoptosis, and suppresses CCL5 in human endometriotic stromal cells. Biol Reprod 2009;81(2):371-7
   PubMed Web of Science ®Google Scholar
• Yang DX, Ma WG, Qu F, Ma BZ. Comparative study on the efficacy of yiweining and gestrinone for post-operational treatment of stage III endometriosis. Chin J Integr Med 2006;12(3):218-20
   PubMedGoogle Scholar
• Collins NH, Lessey EC, DuSell CD, Characterization of antiestrogenic activity of the Chinese herb, Prunella vulgaris, using in vitro and in vivo (Mouse Xenograft) models. Biol Reprod 2000;80(2):375-83
   Google Scholar
• Pezzuto JM. The phenomenon of resveratrol: redefining the virtues of promiscuity. Ann NY Acad Sci 2011;1215:123-30
   PubMed Web of Science ®Google Scholar
• Szekeres T, Saiko P, Fritzer-Szekeres M, Chemopreventive effects of resveratrol and resveratrol derivatives. Ann NY Acad Sci 2011;1215:89-95
   PubMed Web of Science ®Google Scholar
• Delmas D, Jannin B, Cherkaoui-Malki M, Latruffe N. Inhibitory effect of resveratrol on the of human and rat hepatic derived cell lines. Oncol Rep 2000;7:847-52
   PubMed Web of Science ®Google Scholar
• Delmas D, Passilly-Degrace P, Jannin B, Resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells. Int J Mol Med 2002;10:193-9
   PubMed Web of Science ®Google Scholar
• Delmas D, Rebe C, Lacour S, Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death inducing signaling complex in colon cancer cells. J Biol Chem 2003;278:41482-90
   PubMed Web of Science ®Google Scholar
• Delmas D, Rebe C, Micheau O, Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptors ligands in colon carcinoma cells. Oncogene 2004;23:8979-86
   PubMed Web of Science ®Google Scholar
• Marel AC, Lizard G, Izard JC, Effect of resveratrol derived molecules on the proliferation and the cell cycle progression of human tumoral cells. Mol Nut Food Res 2008;52:538-48
   PubMed Web of Science ®Google Scholar
• Lancon A, Delmas D, Osman H, Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process. Biochem Biophys Res Commun 2004;316:1132-7
   PubMed Web of Science ®Google Scholar
• Lancon A, Hanet N, Jannin B, Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes. Drug Metab Dispos 2007;35:699-703
   PubMed Web of Science ®Google Scholar
• Baarine M, Thandapilly SJ, Louis XL, Pro-apoptotic versus anti-apoptotic properties of dietary resveratrol on tumoral and normal cardiac cells. Genes Nutr 2011;6(2):161-9
   PubMed Web of Science ®Google Scholar
• Bruner-Tran KL, Osteen KG, Taylor HS, Resveratrol inhibits development of experimental endometriosis in vivo and reduces endometrial stromal cell invasiveness in vitro. Biol Reprod 2011;84(1):106-12
   PubMed Web of Science ®Google Scholar
• Jackson LW, Schisterman EF, Dey-Rao R, Oxidative stress and endometriosis. Hum Reprod 2005;20(7):2014-20
   PubMed Web of Science ®Google Scholar
• Arumugam K, Dip YC. Endometriosis and infertility: the role of exogenous lipid peroxides in the peritoneal fluid. Fertil Steril 1995;63:198-9
   PubMed Web of Science ®Google Scholar
• Murphy AA, Palinski W, Rankin S, Evidence for oxidatively modified lipid-protein complexes in endometrium and endometriosis. Fertil Steril 1998;69:1092-4
   PubMed Web of Science ®Google Scholar
• Donnez J, Van Langendonckt A, Casanas-Roux F, Current thinking on the pathogenesis of endometriosis. Gynecol Obstet Invest 2002;54(Suppl 1):52-8
   PubMedGoogle Scholar
• Mier-Cabrera J, Jimenez-Zamudio L, Garcia-Latorre E, Quantitative and qualitative peritoneal immune profiles, T-cell apoptosis and oxidative stress-associated characteristics in women with minimal and mild endometriosis. BJOG 2011;118(1):6-16
   PubMed Web of Science ®Google Scholar
• Mier-Cabrera J, Aburto-Soto T, Burrola-Mendez S, Women with endometriosis improved their peripheral antioxidant markers after the application of a high antioxidant diet. Reprod Biol Endocrinol 2009;7:54
   PubMed Web of Science ®Google Scholar
• Mier-Cabrera J, Genera-Garcia M, De la Jara-Diaz J, Effect of vitamins C and E supplementation on peripheral oxidative stress markers and pregnancy rate in women with endometriosis. Int J Gynaecol Obstet 2008;100(3):252-6
   PubMed Web of Science ®Google Scholar
• Sesti F, Capozzolo T, Pietropolli A, Recurrence rate of endometrioma after laparoscopic cystectomy: a comparative randomized trial between post-operative hormonal suppression treatment or dietary therapy vs. placebo. Eur J Obstet Gynecol Reprod Biol 2009;147(1):72-7
   PubMed Web of Science ®Google Scholar
• Panina P, Mariani M, Camisa B, The selective vitamin D receptor agonist elocalcitol reduces endometriotic lesion development in mice by inhibiting peritoneal inflammation. Abstract Book. 11th World Congress on Endometriosis; 2011. p. 188
   Google Scholar
• Vigano P, Lattuada D, Mangioni S, Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system. J Mol Endocrinol 2006;36(3):415-24
   PubMed Web of Science ®Google Scholar
• Sharma I, Dhawan V, Saha SC, Dhaliwal LK. In vitro effects of peroxisome proliferator-activated receptor-gamma ligands on gene expression in lipopolysaccharide-induced endometrial and endometriotic stromal cells. Fertil Steril 2011;95(2):829-31
   PubMed Web of Science ®Google Scholar
• Moravek MB, Ward EA, Lebovic DI. Thiazolidinediones as therapy for endometriosis: a case series. Gynecol Obstet Invest 2009;68(3):167-70
   PubMed Web of Science ®Google Scholar
• Lebovic DI, Kir M, Casey CL. Peroxisome proliferator-activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis. Fertil Steril 2004;82(Suppl 3):1008-13
   PubMed Web of Science ®Google Scholar
• Aytan H, Caliskan AC, Demirturk F, Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces the size of experimental endometriosis in the rat model. Aust NZ J Obstet Gynaecol 2007;47:321-5
   PubMed Web of Science ®Google Scholar
• Demirturk F, Aytan H, Caliskan AC, Effect of peroxisome proliferator-activated receptor-gamma agonist rosiglitazone on the induction of endometriosis in an experimental rat model. J Soc Gynecol Investig 2006;13:58-62
   PubMedGoogle Scholar
• Herington JL, Crispens MA, Carvalho-Macedo AC, Development and prevention of postsurgical adhesions in a chimeric mouse model of experimental endometriosis. Fertil Steril 2011;95:1295-301
   PubMed Web of Science ®Google Scholar
• Lebovic DI, Mwenda JM, Chai DC, Peroxisome proliferator-activated receptor-gamma receptor ligand partially prevents the development of endometrial explants in baboons: a prospective, randomized, placebo-controlled study. Endocrinology 2010;151:1846-52
   PubMed Web of Science ®Google Scholar
• Lebovic DI, Mwenda JM, Chai DC, PPAR-gamma receptor ligand induces regression of endometrial explants in baboons: a prospective, randomized, placebo- and drug-controlled study. Fertil Steril 2007;88:1108-19
   PubMed Web of Science ®Google Scholar
• Mckinnon BD, Bersinger NA, Mueller MD. Regulation of IL-6 in cultured endometrial stromal cells by thiazolidiones. Abstract Book. 11th World Congress on Endometriosis; 2011. p. 182
   Google Scholar
• Elden H, Ladfors L, Fagevik Olsen M, Effects of acupuncture and stabilising exercises as adjunct to standard treatment in pregnant women with pelvic girdle pain. BMJ 2005;330:761
   PubMed Web of Science ®Google Scholar
• Highfield E, Laufer M, Schnyer R, Adolescent endometriosis-related pelvic pain treated with acupuncture: two case reports. Altern Complement Med 2006;12:317-22
   PubMed Web of Science ®Google Scholar
• Lund I, Lundeberg T, Lonnberg L, Svennson E. Decrease of pregnant women's pelvic pain after acupuncture. Acta Obstet Gynecol 2006;85:12-19
   PubMed Web of Science ®Google Scholar
• Gerhard I, Postneek F. Auricular acupuncture in the treatment of female infertility. Gynecol Endocrinol 1992;6:171-81
   PubMed Web of Science ®Google Scholar
• Helms JM. Acupuncture for the management of primary dysmenorrhea. Obstet Gynecol 1987;69:51-6
   PubMed Web of Science ®Google Scholar
• Pouresmail Z, Ibrahimzadeh R. Effects of acupressure and ibuprofen on the severity of primary dysmenorrhea. J Tradit Chin Med 2002;22:205-10
   PubMedGoogle Scholar
• French L. Dysmenorrhea. Am Fam Physician 2005;71(2):285-91
   PubMed Web of Science ®Google Scholar
• French L. Dysmenorrhea in adolescents: diagnosis and treatment. Paediatr Drugs 2008;10(1):1-7
   PubMedGoogle Scholar
• Rubi-Klein K, Kucera-Sliutz E, Nissel H, Is acupuncture in addition to conventional medicine effective as pain treatment for endometriosis? A randomised controlled cross-over trial. Eur J Obstet Gynecol Reprod Biol 2010;153(1):90-3
   PubMed Web of Science ®Google Scholar
• McLaren J. Vascular endothelial growth factor and endometriotic angiogenesis. Hum Reprod Update 2000;6:45-55
   PubMed Web of Science ®Google Scholar
• Cosin R, Gilabert-Estelles J, Ramon LA, Vascular endothelial growth factor polymorphisms (-460C/T, +405G/C, and 936C/T) and endometriosis: their influence on vascular endothelial growth factor expression. Fertil Steril 2009;92:1214-20
   PubMed Web of Science ®Google Scholar
• Tan XJ, Lang JH, Liu DY, Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis. Fertil Steril 2002;78:148-53
   PubMed Web of Science ®Google Scholar
• Ramon LA, Braza-Boils A, Gilabert-Estelles J, MicroRNAs expression in endometriosis and their relation to angiogenic factors. Hum Reprod 2011;26(5):1082-90
   PubMed Web of Science ®Google Scholar
• Machado DE, Abrao MS, Berardo PT, Vascular density and distribution of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) are significantly higher in patients with deeply infiltrating endometriosis affecting the rectum. Fertil Steril 2008;90(1):148-55
   PubMed Web of Science ®Google Scholar
• Laschke MW, Menger MD. In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis. Hum Reprod Update 2007;13:331-42
   PubMed Web of Science ®Google Scholar
• Laschke MW, Elitzsch A, Vollmar B, Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions. Hum Reprod 2006;21:262-8
   PubMed Web of Science ®Google Scholar
• Imesch P, Samartzis EP, Schneider M, Inhibition of transcription, expression, and secretion of the vascular epithelial growth factor in human epithelial endometriotic cells by romidepsin. Fertil Steril 2011;95(5):1579-83
   PubMed Web of Science ®Google Scholar
• Laschke MW, Elitzsch A, Scheuer C, Rapamycin induces regression of endometriotic lesions by inhibiting neovascularization and cell proliferation. Br J Pharmacol 2006;149(2):137-44
   PubMed Web of Science ®Google Scholar
• Xu H, Lui WT, Chu CY, Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model. Hum Reprod 2009;24(3):608-18
   PubMed Web of Science ®Google Scholar
• Laschke MW, Schwender C, Scheuer C, Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo. Hum Reprod 2008;23(10):2308-18
   PubMed Web of Science ®Google Scholar
• Ricci AG, Olivares CN, Bilotas MA, Effect of vascular endothelial growth factor inhibition on endometrial implant development in a murine model of endometriosis. Reprod Sci 2011;18(7):614-22
   PubMed Web of Science ®Google Scholar
• Becker CM, Beaudry P, Funakoshi T, Circulating endothelial progenitor cells are up-regulated in a mouse model of endometriosis. Am J Pathol 2011;178(4):1782-91
   PubMed Web of Science ®Google Scholar
• Van Langendonckt A, Donnez J, Defrere S, Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises. Mol Hum Reprod 2008;14(5):259-68
   PubMed Web of Science ®Google Scholar
• Novella-Maestre E, Carda C, Noguera I, Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis. Hum Reprod 2009;24(5):1025-35
   PubMed Web of Science ®Google Scholar
• Delgado-Rosas F, Gomez R, Ferrero H, The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis. Reproduction 2011;142(5):745-55
   PubMed Web of Science ®Google Scholar
• Klein TW. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol 2005;5:400-11
   PubMed Web of Science ®Google Scholar
• De Petrocellis L, Melck D, Palmisano A, The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc Natl Acad Sci USA 1998;95:8375-80
   PubMed Web of Science ®Google Scholar
• Melck D, De Petrocellis L, Orlando P, Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Endocrinology 2000;141:118-26
   PubMed Web of Science ®Google Scholar
• Gomez del Pulgar T, Velasco G, Sanchez C, De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis. Biochem J 2002;363:183-8
   PubMed Web of Science ®Google Scholar
• Bouaboula M, Poinot-Chazel C, Bourrie B, Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem J 1995;312(Pt 2):637-41
   PubMedGoogle Scholar
• Rueda D, Galve-Roperh I, Haro A, Guzman M. The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase. Mol Pharmacol 2000;58:814-20
   PubMed Web of Science ®Google Scholar
• Akhmetshina A, Dees C, Busch N, The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis. Arthritis Rheum 2009;60:1129-36
   PubMed Web of Science ®Google Scholar
• Defer N, Wan J, Souktani R, The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy. FASEB J 2009;23:2120-30
   PubMed Web of Science ®Google Scholar
• Garcia-Gonzalez E, Selvi E, Balistreri E, Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts. Rheumatology 2009;48:1050-6
   PubMed Web of Science ®Google Scholar
• Julien B, Grenard P, Teixeira-Clerc F, Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology 2005;128:742-55
   PubMed Web of Science ®Google Scholar
• Michalski CW, Maier M, Erkan M, Cannabinoids reduce markers of inflammation and fibrosis in pancreatic stellate cells. PLoS One 2008;3:e1701
   PubMed Web of Science ®Google Scholar
• Munoz-Luque J, Ros J, Fernandez-Varo G, Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats. J Pharmacol Exp Ther 2008;324:475-83
   PubMed Web of Science ®Google Scholar
• Teixeira-Clerc F, Julien B, Grenard P, CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat Med 2006;12:671-6
   PubMed Web of Science ®Google Scholar
• Guindon J, Hohmann AG. Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. Br J Pharmacol 2008;153:319-34
   PubMed Web of Science ®Google Scholar
• Pacher P, Batkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 2006;58:389-462
   PubMed Web of Science ®Google Scholar
• Tsou K, Lowitz KA, Hohmann AG, Suppression of noxious stimulus-evoked expression of Fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist. Neuroscience 1996;70:791-8
   PubMed Web of Science ®Google Scholar